COMMUNIQUÉS West-GlobeNewswire

-
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit
10/10/2024 -
Construction of JinMed's New Facility Begins in Chuzhou, China
10/10/2024 -
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
10/10/2024 -
Information on the total number of voting rights and shares
09/10/2024 -
Informations sur le nombre total de droits de vote et d'actions
09/10/2024 -
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
09/10/2024 -
Publication relating to transparency notifications
09/10/2024 -
Publication relative à des notifications de transparence
09/10/2024 -
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
09/10/2024 -
ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
09/10/2024 -
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
09/10/2024 -
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/10/2024 -
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
09/10/2024 -
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
09/10/2024 -
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/10/2024 -
Premier Health Announces Notice of Award for Independent Labour for Nordic Customers in Quebec
09/10/2024 -
Ipsen - September 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
09/10/2024 -
Ipsen - Septembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
09/10/2024 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2024
09/10/2024
Pages